A Case of Primary Resistance to Gefitinib due to Novel Deletion-Insertion Mutation of EGFR Exon 19 in NSCLC

被引:5
作者
Xia, Peiyi [1 ]
Liu, Enjie [1 ]
Li, Pan [1 ]
Li, Wencai [1 ]
Jiang, Guozhong [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Pathol, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China
关键词
D O I
10.1016/j.jtho.2019.01.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E117 / E119
页数:4
相关论文
共 2 条
[1]  
Deng L., 2018, EXPET OPIN EMERG DRU, P1
[2]   Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations [J].
Wang, Jun ;
Wang, Baocheng ;
Chu, Huili ;
Yao, Yunfeng .
ONCOTARGETS AND THERAPY, 2016, 9 :3711-3726